147 related articles for article (PubMed ID: 31576147)
41. PCAT1 promotes the proliferative and migratory potentials of ovarian cancer via targeting NEK2.
Liu XL; Liu HM; Han N; Li FH; Sun F; Fan DM; Xu Q
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8239-8248. PubMed ID: 31646554
[TBL] [Abstract][Full Text] [Related]
42. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
43. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.
Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B
J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702
[TBL] [Abstract][Full Text] [Related]
44. LINC00968 accelerates the progression of epithelial ovarian cancer via mediating the cell cycle progression.
Yao N; Sun JQ; Yu L; Ma L; Guo BQ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4642-4649. PubMed ID: 31210289
[TBL] [Abstract][Full Text] [Related]
45. Effects of LncRNA KCNQ1OT1 on proliferation and migration of ovarian cancer cells by Wnt/β-catenin.
Luo ZP; Jin H
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8788-8794. PubMed ID: 31696465
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression.
Zheng B; Liu F; Zeng L; Geng L; Ouyang X; Wang K; Huang Q
Med Sci Monit; 2018 May; 24():3103-3112. PubMed ID: 29752805
[TBL] [Abstract][Full Text] [Related]
47. The role of nucleolar spindle-associated protein 1 in human ovarian cancer.
Zhang Y; Huang K; Cai H; Chen S; Sun D; Jiang P
J Cell Biochem; 2020 Nov; 121(11):4397-4405. PubMed ID: 32031285
[TBL] [Abstract][Full Text] [Related]
48. Acquisition of paclitaxel resistance via PI3K‑dependent epithelial‑mesenchymal transition in A2780 human ovarian cancer cells.
Du F; Wu X; Liu Y; Wang T; Qi X; Mao Y; Jiang L; Zhu Y; Chen Y; Zhu R; Han X; Jin J; Ma X; Hua D
Oncol Rep; 2013 Sep; 30(3):1113-8. PubMed ID: 23807572
[TBL] [Abstract][Full Text] [Related]
49. Knockdown of ALPK2 inhibits the development and progression of Ovarian Cancer.
Zhu X; Yan S; Xiao S; Xue M
Cancer Cell Int; 2020; 20():267. PubMed ID: 32595416
[TBL] [Abstract][Full Text] [Related]
50. Long non-coding RNA LINC00858 aggravates the oncogenic phenotypes of ovarian cancer cells through miR-134-5p/RAD18 signaling.
Xue H; Wu Z; Rao D; Zhuo B; Chen Q
Arch Gynecol Obstet; 2020 Nov; 302(5):1243-1254. PubMed ID: 32875345
[TBL] [Abstract][Full Text] [Related]
51. [Long non-coding RNA LOC101927476 inhibits invasion, migration, and proliferation of ovarian cancer cell lines].
Zhao PF; Nan YB; Wang YT; Li B; Liu ZH
Zhonghua Zhong Liu Za Zhi; 2022 Jan; 44(1):104-111. PubMed ID: 35073656
[No Abstract] [Full Text] [Related]
52. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
53. [*OPCML gene transferred by recombinant lentiviruses in vitro and its inhibition to ovarian cancer cells].
Yao DS; Li L; Garson K; Vanderhyden BC
Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):333-8. PubMed ID: 16762191
[TBL] [Abstract][Full Text] [Related]
54. Low expression of FXYD5 reverses the cisplatin resistance of epithelial ovarian cancer cells.
Liu YK; Jia YJ; Liu SH; Shi HJ; Ma J
Histol Histopathol; 2021 May; 36(5):535-545. PubMed ID: 33570156
[TBL] [Abstract][Full Text] [Related]
55. CircRNA hsa_circ_0013958 may contribute to the development of ovarian cancer by affecting epithelial-mesenchymal transition and apoptotic signaling pathways.
Pei C; Wang H; Shi C; Zhang C; Wang M
J Clin Lab Anal; 2020 Jul; 34(7):e23292. PubMed ID: 32157748
[TBL] [Abstract][Full Text] [Related]
56. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
Luo HB; Li B; Yuan WG; Xu CR
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
[TBL] [Abstract][Full Text] [Related]
57. Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/β-catenin signaling pathway.
Guo C; Wang X; Chen LP; Li M; Li M; Hu YH; Ding WH; Wang X
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3703-3712. PubMed ID: 29949143
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of p22
Li Q; Feng X; Niu F; Yang J; Xu Y; Pu X; Chen J; Fan X; Jiang B; Huang Q
J Cancer; 2021; 12(14):4277-4287. PubMed ID: 34093828
[TBL] [Abstract][Full Text] [Related]
59. Effects of alisol B 23-acetate on ovarian cancer cells: G1 phase cell cycle arrest, apoptosis, migration and invasion inhibition.
Zhang LL; Xu YL; Tang ZH; Xu XH; Chen X; Li T; Ding CY; Huang MQ; Chen XP; Wang YT; Yuan XF; Lu JJ
Phytomedicine; 2016 Jul; 23(8):800-9. PubMed ID: 27288915
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of Hec1 expression enhances the sensitivity of human ovarian cancer cells to paclitaxel.
Mo QQ; Chen PB; Jin X; Chen Q; Tang L; Wang BB; Li KZ; Wu P; Fang Y; Wang SX; Zhou JF; Ma D; Chen G
Acta Pharmacol Sin; 2013 Apr; 34(4):541-8. PubMed ID: 23474708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
